A standard blood sugar check usually means one of two things: a fasting glucose reading, or an HbA1c result that reflects your average blood glucose over roughly the past three months. Both are useful, and both can look normal for a period while insulin resistance is developing underneath. Fasting insulin and HOMA-IR are two ways of looking at that earlier stage, and they may change before fasting glucose or HbA1c move outside the normal range.
Neither replaces a standard blood sugar test. Both add information that a fasting glucose or HbA1c result does not report on its own, which is part of why there appears to be growing public interest in insulin resistance and metabolic health testing in Australia.
This guide covers what insulin resistance and HOMA-IR measure, what they add to a standard blood sugar result, who might consider testing, and how to test in Australia without a GP referral.
What is insulin resistance, and what does it measure?
Insulin is the hormone that allows cells to take up glucose from the blood for energy. Insulin resistance describes a state where cells respond less efficiently to insulin, so the body produces more of it to keep blood glucose in the normal range. In the earlier stages, this compensation, producing more insulin to do the same job, can keep fasting glucose and HbA1c looking normal even while insulin itself is elevated.
Insulin resistance isn't captured by a single definitive test. A fasting insulin test measures the insulin level in the blood directly, rather than the downstream glucose result that a standard blood sugar test reports. On its own, fasting insulin is one piece of the picture, it's most informative when interpreted alongside glucose and a person's wider health context.
What is HOMA-IR, and how is it different from a standard blood sugar test?
HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a score calculated from fasting insulin and fasting glucose measured together, it's a model-derived estimate of insulin resistance, not something measured directly in the blood. It is not part of a standard blood sugar panel and is not a diagnostic test for diabetes. In Australia, diabetes is diagnosed using fasting glucose, HbA1c, or an oral glucose tolerance test under RACGP and Diabetes Australia criteria, not HOMA-IR.
What HOMA-IR can add is an earlier signal. Because the body typically raises insulin output to compensate before blood glucose starts to rise, insulin-based markers such as HOMA-IR may become abnormal before fasting glucose or HbA1c move outside the normal range. This reflects the usual physiological sequence, compensatory higher insulin preceding glucose changes, rather than a fixed head start: the degree and consistency of this lead time varies between individuals and populations, and has not been precisely quantified for general clinical use. So HOMA-IR offers a different kind of information from a single fasting glucose or HbA1c result, which mainly reports whether blood glucose itself is currently raised.
One practical point on interpretation: there is no single, universally validated HOMA-IR cut-off. Reference ranges differ by population, insulin assay and laboratory, so a result is best interpreted relative to the reporting lab's reference range rather than against a fixed number.
What do insulin resistance and HOMA-IR add to a standard blood sugar test?
A standard blood sugar test and these additional markers report on different things. The table below sets out what each covers.
| Marker | What it reports | Included in a standard blood sugar test? |
|---|---|---|
| Fasting glucose, HbA1c | Current blood glucose and roughly 3-month average | Yes |
| Fasting insulin | How much insulin the body is producing to manage glucose | No |
| HOMA-IR | A model-derived score combining fasting insulin and glucose | No |
For some people, glucose and HbA1c look unremarkable on a standard panel while fasting insulin or HOMA-IR sits outside the typical range. In these cases the additional markers add information a standard test does not report, they don't show the standard test was wrong. Results are best discussed with a GP or other treating practitioner.
Who might consider testing insulin resistance and HOMA-IR?
Insulin resistance and HOMA-IR testing may be relevant for people who want an earlier or fuller picture alongside a standard blood sugar result, including:
- People with a family history of type 2 diabetes
- People already monitoring their weight or metabolic health who want to understand insulin levels as well as glucose
- People whose standard blood sugar results look unremarkable but who have other higher-risk factors, such as difficulty managing weight, PCOS, or a sedentary lifestyle
Insulin resistance is common, and by some estimates affects a majority of people with PCOS; family history, higher body weight and a sedentary lifestyle are also well-recognised risk factors for type 2 diabetes. That said, testing HOMA-IR is not a required or guideline-mandated step for these groups, it's one option that some people in them may find relevant. These markers relate to metabolic health assessment generally, rather than to diagnosing any single condition, and results are best interpreted alongside the rest of a person's health picture. Whether testing is worthwhile is a good thing to consider with a GP or treating practitioner.
How to test insulin resistance and HOMA-IR in Australia
Testing for insulin resistance and HOMA-IR does not require a GP referral. i-screen offers a few ways to test these markers, depending on how much additional detail you want alongside them.
| Test | What it covers | Price |
|---|---|---|
| Insulin Resistance Test | Fasting insulin and glucose, the basis for a HOMA-IR calculation | $69 |
| Metabolic Reset Test | Fasting glucose, insulin and HbA1c alongside a broader metabolic, hormonal and organ-function panel | $249 |
| Diabetes HbA1c Test | HbA1c, for comparison against or alongside insulin-based markers | $39 |
| Oral Glucose Tolerance Test | The standard diagnostic OGTT measures glucose (fasting and 2-hour) after a glucose drink; this panel adds supplementary metabolic markers, insulin at each point, a 1-hour reading, and a HOMA-IR score | $85 |
The additional insulin, 1-hour and HOMA-IR elements are supplementary metabolic markers, not part of the official two-point diagnostic OGTT.
Ordering is straightforward: order online, collect a sample at a partner collection centre, and view results through the online dashboard once a NATA-accredited lab has processed them.
For a wider view of metabolic health, including blood sugar, hormones and nutrient markers, the i-screen Support Healthy Weight, Metabolism & Blood Sugar hub groups the related tests together in one place.
Making sense of the results, and how often to check again
Insulin resistance and HOMA-IR results are best read alongside a standard glucose or HbA1c result and other factors such as weight, activity levels, family history and any existing metabolic conditions, not in isolation. A GP or other treating practitioner is the right person to interpret what a specific result means for an individual and whether any follow-up is needed.
There is no single, universally agreed interval for retesting fasting insulin or HOMA-IR. Insulin resistance can improve with sustained physical activity and weight loss over weeks to months, though the degree of improvement varies between individuals and may partially reverse if the changes aren't maintained. Because it can shift over months to years, some people choose to retest periodically as part of an ongoing metabolic health picture, particularly after a lifestyle change or if risk factors are present. How often that makes sense is a decision for a person's GP or practitioner, based on their own results, risk profile and goals, rather than a fixed schedule.
This article is for general information and does not replace advice from a qualified health practitioner. Always discuss test results with a GP or another treating practitioner.
